¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 83¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 173¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ CAGR 11.0%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
º¸°í¼ ¹üÀ§ |
º¸°í¼ »ó¼¼ ³»¿ë |
±âÁØ¿¬µµ |
2024³â |
2025³â ½ÃÀå ±Ô¸ð |
83¾ï 5,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2020-2024³â |
¿¹Ãø ±â°£ |
2025-2032³â |
¿¹Ãø ±â°£ : 2025-2032³â CAGR |
11.00% |
2032³â ±Ý¾× ¿¹Ãø |
173¾ï 4,000¸¸ ´Þ·¯ |
µµÇ¥. 2025³â Áö¿ªº° À¯¼¼Æ÷ºÐ¼® ½ÃÀå Á¡À¯À²(%)

¼¼°è À¯¼¼Æ÷ºÐ¼® ½ÃÀåÀº ¿¬±¸, ÀÓ»ó Áø´Ü ¹× Ä¡·á ¸ð´ÏÅ͸µ¿¡¼ À¯¼¼Æ÷ºÐ¼®ÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áö³ ¼ö³â°£ ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. À¯¼¼Æ÷ºÐ¼®Àº °·ÂÇÑ ·¹ÀÌÀú ±â¹Ý ±â¼ú·Î, ±¤¼±À» ÅëÇØ À¯Ã¼ ¼ÓÀ» È帣´Â ¼¼Æ÷/ÀÔÀÚÀÇ »ý¸®Àû, »ýÈÇÐÀû Ư¼ºÀ» ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. Çü±¤ ÇÁ·Îºê·Î ¿°»öÇÏ°í ºû »ê¶õ°ú Çü±¤ ¹ß±¤À» ±â¹ÝÀ¸·Î ºÐ¼®ÇÔÀ¸·Î½á, À¯¼¼Æ÷ºÐ¼®Àº ¼¼Æ÷³ª ÀÔÀÚÀÇ ¹°¸®Àû, ÈÇÐÀû Ư¼ºÀ» ¼¼Æ÷ ´ÜÀ§·Î Á¶»çÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯¼¼Æ÷ºÐ¼® Àåºñ, ½Ã¾à, ¼ÒÇÁÆ®¿þ¾îÀÇ ¹ßÀüÀ¸·Î º¹ÀâÇÑ ´Ù»ö ¿ëµµ¸¦ ºü¸£°í Á¤È®ÇÏ°Ô ºÐ¼®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ´Ü¹éÁúüÇÐ ¹× Áٱ⼼Æ÷ ¿¬±¸ÀÇ È®´ë, ¸ÂÃãÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡´Â Àü ¼¼°è¿¡¼ À¯¼¼Æ÷ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
¼¼°è À¯¼¼Æ÷ºÐ¼® ½ÃÀåÀº ¸é¿ªÇÐ ¹× Ç÷¾×ÇÐ ºÎ¹®ÀÇ ¿¬±¸ Ȱµ¿ Áõ°¡, Áٱ⼼Æ÷ ¿¬±¸ ÀÚ±Ý Áõ°¡, Àü ¼¼°è HIV/AIDS ¹× ¾Ï À¯º´·ü Áõ°¡, À¯¼¼Æ÷ºÐ¼® ÀåºñÀÇ ±â¼ú ¹ßÀü µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª À¯¼¼Æ÷ºÐ¼® Á¦Ç°ÀÇ ³ôÀº ºñ¿ëÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä«¿Í °°Àº ½ÅÈï ½ÃÀåÀº ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ý¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ µ¿¹Ý Áø´Ü¿¡ À¯¼¼Æ÷ºÐ¼®ÀÌ È°¿ëµÉ ¼ö ÀÖ´Â ±âȸµµ ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À Á¦Á¶ ¹× ½Å¾à°³¹ßÀ» À§ÇÑ Çü±¤ Ȱ¼ºÈ ¼¼Æ÷ ¼±º°(FACS)ÀÇ Ã¤ÅÃÀº ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¶Ç ´Ù¸¥ ÁÖ¿ä µ¿ÇâÀÔ´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
- ¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.
- ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¸ÅÃâ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
- ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
- ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è À¯¼¼Æ÷ºÐ¼® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿äÀ» Á¦°øÇÕ´Ï´Ù.
- ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
- À¯¼¼Æ÷ºÐ¼® ¼¼°è ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
- ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è À¯¼¼Æ÷ºÐ¼® ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
- ¸®Æ÷Æ® ¼³¸í
- °³¿ä
- COM(Coherent Opportunity Map)
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¿µÇ⠺м®
- ½ÃÀå µ¿Çâ
- ±ÔÁ¦ ½Ã³ª¸®¿À
- ±â¼úÀÇ Áøº¸
- Á¦Á¶¾÷ü ¸ÅÃâ
- Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
- Á¦Ç° ¹ß¸Å/½ÂÀÎ
- ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
- PEST ºÐ¼®
- PorterÀÇ »ê¾÷ ºÐ¼®
Á¦4Àå ¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ
- ÀüüÀûÀÎ ¿µÇâ
- Á¤ºÎ ±¸»ó
- ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
Á¦5Àå ¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå, ±â¼úº°, 2020-2032³â(10¾ï ´Þ·¯)
Á¦6Àå ¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â(10¾ï ´Þ·¯)
- ¼·Ð
- ¾Ö³Î¶óÀÌÀú
- ¼ÒÅÍ
- ½Ã¾à¡¤¼Ò¸ðǰ
Á¦7Àå ¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)
- ¼·Ð
- º´¿ø
- ÀÓ»ó °Ë»ç ½ÇÇè½Ç
- ½ÇÇè½Ç
Á¦8Àå ¼¼°èÀÇ À¯¼¼Æ÷ºÐ¼® ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)
- ¼·Ð
- ºÏ¹Ì
- ¶óƾ¾Æ¸Þ¸®Ä«
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- 秵- ¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï ±¸µµ
- ±â¾÷ °³¿ä
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- BD
- Bio-Rad Laboratories, Inc.
- Miltenyi BIoTec GmbH
- Sysmex Corporation
- Agilent Technologies, Inc.
- Danaher
- Enzo Life Sciences, Inc.
- Cytek Biosciences
- Sartorius AG
- BioLegend, Inc.
- Beckman Coulter, Inc.
- FlowMetric
Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡
- ¿î¸íÀÇ ¼ö·¹¹ÙÄû
- COM(Coherent Opportunity Map)
Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
KSA 25.04.03
Global Flow Cytometry Market is estimated to be valued at USD 8.35 Bn in 2025 and is expected to reach USD 17.34 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.0% from 2025 to 2032.
Report Coverage |
Report Details |
Base Year: |
2024 |
Market Size in 2025: |
USD 8.35 Bn |
Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: |
11.00% |
2032 Value Projection: |
USD 17.34 Bn |
Figure. Flow Cytometry Market Share (%), By Region 2025

The global flow cytometry market has been witnessing steady growth over the past few years due to the increasing applications of flow cytometry in research, clinical diagnostics, and treatment monitoring. Flow cytometry is a powerful laser-based technology used for analyzing the physiometric and biochemical characteristics of cells/particles as they flow in a fluid stream through a beam of light. Through staining with fluorescent probes and analysis on the basis of light scattering and fluorescence emission, flow cytometry allows examining the physical and chemical characteristics of cells and particles on a single-cell basis. Advancements in flow cytometry instruments, reagents, and software have enabled analyzing complex multicolor applications with high speed and accuracy. The growing proteomics and stem cell research along with increasing focus on personalized medicine are some of the key factors driving the demand for flow cytometry worldwide.
Market Dynamics:
The global flow cytometry market is driven by factors such as increasing research activity in the fields of immunology and hematology, growing stem cell research funding, rising prevalence of HIV/AIDS and cancer worldwide, and technological advancements in flow cytometry instruments. However, high cost of flow cytometry products is a major restraint for the market. Meanwhile, emerging markets such as Asia Pacific and Latin America provide significant growth opportunities for market players. Growing focus on personalized medicine approaches also presents opportunity for use of flow cytometry in companion diagnostics. Adoption of fluorescence-activated cell sorting (FACS) for biomanufacturing and drug discovery is another key trend expected to propel the market growth during the forecast period.
Key Features of the Study:
- This report provides an in-depth analysis of the global flow cytometry market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global flow cytometry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study includes Luminex Corporation, Thermo Fisher Scientific, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., and FlowMetric.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global flow cytometry market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global flow cytometry market.
Detailed Segmentation-
- By Technology:
- By Product Type:
- Analyzer
- Sorter
- Reagent & Consumables
- By End User:
- Hospitals
- Clinical Testing Laboratories
- Research Laboratories
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- BD
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH.
- Sysmex Corporation
- Agilent Technologies, Inc.
- Danaher
- Enzo Life Sciences, Inc.
- Cytek Biosciences
- Sartorius AG
- BioLegend, Inc.
- Beckman Coulter, Inc.
- FlowMetric
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Regulatory Scenario
- Technological Advancements
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Flow Cytometry Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
5. Global Flow Cytometry Market, By Technology, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Cell Based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bead Based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Flow Cytometry Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Analyzer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sorter
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reagent & Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Flow Cytometry Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Testing Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Flow Cytometry Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Luminex Corporation*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Miltenyi Biotec GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Technologies, Inc.
- Danaher
- Enzo Life Sciences, Inc.
- Cytek Biosciences
- Sartorius AG
- BioLegend, Inc.
- Beckman Coulter, Inc.
- FlowMetric
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact